Drugs / Omega-3 (EPA+DHA)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05121766 | Jan 2022 → Apr 2023 | COVID-19 | Hackensack Meridian Health | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-3 (EPA+DHA) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05121766 ↗ |